Stock 1701 CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News China Chemical & Pharmaceutical Co., Ltd.

Equities

1701

TW0001701001

End-of-day quote Taiwan S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
22.05 TWD +0.68% Intraday chart for China Chemical & Pharmaceutical Co., Ltd. +0.23% -9.45%
05-28 China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024 CI
05-15 China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Year Ended December 31, 2023
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend, Payable on August 22, 2023
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Fiscal Year 2022
CI
China Chemical & Pharmaceutical Co., Ltd. announced a financing transaction
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
China Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
China Chemical & Pharmaceutical : To announce that 2022Q2 Consolidated Financial Statements reported to the Board of Directors.
PU
Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company
CI
MegaPro Biomedical, Two Others Form Non-Invasive Drug Development JV
MT
China Chemical & Pharmaceutical : Announcement to correct the details of disclosure of endorsement guarantee information from March 2010 to May 2011
PU
China Chemical & Pharmaceutical : Correction of all consolidated ,individual reports for 2021 and the 1st quarter of consolidated report of 2022 attached to the part2 of the financial report
PU
China Chemical & Pharmaceutical : Announced the appointment of the chairman of the board of directors on behalf of the CCPC's important subsidiary "Chunghwa Yuming Healthcare Co., Ltd".
PU
China Chemical & Pharmaceutical : Announced by CCPC on behalf of its subsidiary ,CYH, that its board of directors resolved to re-elect the director
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1701 Stock
  4. News China Chemical & Pharmaceutical Co., Ltd.